Skip to main content
Fig. 5 | BMC Cardiovascular Disorders

Fig. 5

From: Combining genetic proxies of drug targets and time-to-event analyses from longitudinal observational data to identify target patient populations

Fig. 5

Effect of ACE rs4968782 on time to cardiovascular (CV) death/heart transplant from first atrial fibrillation (AF) diagnosis in (a) unmatched and (b) matched individuals of European ancestry, and time to heart failure (HF) rehospitalization or CV death/heart transplant in (c) unmatched and (d) matched participants of any continental ancestry. Carriers of GA or AA genotype showed better survival for rehospitalization and severe cardiovascular outcome compared to individuals with GG genotype

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us